182.78
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $182.78, with a volume of 795.79K.
It is down -0.70% in the last 24 hours and down -0.07% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$184.07
Open:
$182.71
24h Volume:
795.79K
Relative Volume:
0.84
Market Cap:
$20.44B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
21.86
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
+2.44%
1M Performance:
-0.07%
6M Performance:
+11.46%
1Y Performance:
+22.94%
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DGX
Quest Diagnostics Inc
|
182.78 | 20.58B | 10.52B | 999.00M | 1.22B | 8.3628 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
Apr-02-25 | Initiated | Redburn Atlantic | Buy |
Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Dec-10-24 | Resumed | Jefferies | Buy |
Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
Aug-28-24 | Resumed | Evercore ISI | In-line |
Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
Jan-03-24 | Initiated | Barclays | Equal Weight |
Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
Jun-29-23 | Initiated | Piper Sandler | Neutral |
May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
Jan-23-23 | Initiated | Evercore ISI | In-line |
Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
Feb-23-22 | Downgrade | UBS | Buy → Neutral |
Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
May-04-21 | Upgrade | UBS | Neutral → Buy |
Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
Oct-21-20 | Upgrade | Argus | Hold → Buy |
Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-08-20 | Initiated | Wells Fargo | Underweight |
Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
Mar-18-19 | Resumed | Credit Suisse | Neutral |
Jan-31-19 | Downgrade | Argus | Buy → Hold |
Jan-17-19 | Initiated | UBS | Neutral |
Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
How supply chain issues affect Quest Diagnostics Incorporated stockWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
Published on: 2025-10-13 08:58:36 - newser.com
How to read the order book for Quest Diagnostics IncorporatedWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollar2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com
Is Quest Diagnostics Incorporated stock cheap compared to fundamentalsJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com
What To Expect From Quest Diagnostics’ Next Quarterly Earnings Report - Barchart.com
Published on: 2025-10-12 22:32:22 - newser.com
Sivik Global Healthcare LLC Invests $4.49 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
Blair William & Co. IL Buys 38,588 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by Galvin Gaustad & Stein LLC - MarketBeat
Ranking Quest Diagnostics Incorporated among high performing stocks via toolsBuy Signal & Weekly Setup with ROI Potential - newser.com
Trend analysis for Quest Diagnostics Incorporated this weekAnalyst Upgrade & Consistent Profit Focused Trading Strategies - newser.com
Q3 EPS Estimate for Quest Diagnostics Decreased by Analyst - MarketBeat
Rice Partnership LLC Invests $3.33 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Game Plan Financial Advisors LLC Cuts Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Can Quest Diagnostics Incorporated stock sustain breakout momentumSwing Trade & Free Weekly Watchlist of Top Performers - newser.com
Vontobel Holding Ltd. Boosts Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How Quest Diagnostics Incorporated (QDI) stock responds to job market shifts2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceMarket Sentiment Report & Technical Pattern Alert System - newser.com
Quest Diagnostics' (DGX) Buy (B) Rating Reiterated at Weiss Ratings - MarketBeat
Will Quest Diagnostics Incorporated stock hit analyst forecastsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
What macro factors could drive Quest Diagnostics Incorporated stock higher2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
Bar Harbor Wealth Management Invests $2.73 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Janney Montgomery Scott LLC Has $3.62 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Evercore ISI Group Raises Price Target for Quest Diagnostics (DG - GuruFocus
Quest Diagnostics (NYSE:DGX) Price Target Raised to $190.00 - MarketBeat
Evercore ISI Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains In Line Rating - MarketScreener
Leerink Partners Adjusts Price Target on Quest Diagnostics to $203 From $192, Maintains Outperform Rating - MarketScreener
Is Quest Diagnostics Incorporated (QDI) stock a top pick for value investorsJuly 2025 Movers & Low Drawdown Momentum Ideas - newser.com
2,014 Shares in Quest Diagnostics Incorporated $DGX Purchased by Gratus Wealth Advisors LLC - MarketBeat
Appleton Partners Inc. MA Boosts Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 2,526 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
OLD National Bancorp IN Raises Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Why Quest Diagnostics Incorporated stock could rally stronglyJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Will Quest Diagnostics Incorporated continue its uptrend2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
Quest Diagnostics Incorporated stock daily chart insightsJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Quest Diagnostics: Investing In Healthcare's Future Today (NYSE:DGX) - Seeking Alpha
How Quest Diagnostics Incorporated (QDI) stock behaves in tightening cycles2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Evaluating Quest Diagnostics Incorporated with trendline analysis2025 Price Momentum & Smart Money Movement Tracker - newser.com
Technical analysis overview for Quest Diagnostics Incorporated stockTrade Risk Report & Community Consensus Stock Picks - newser.com
What to expect from Quest Diagnostics Incorporated in the next 30 daysWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
74,250 Shares in Quest Diagnostics Incorporated $DGX Bought by Boston Common Asset Management LLC - MarketBeat
QRG Capital Management Inc. Buys 11,008 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
J. Safra Sarasin Holding AG Grows Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
Copeland Capital Management LLC Has $31.66 Million Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How Quest Diagnostics Incorporated (QDI) stock moves in volatile trading sessionsJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Analyzing Quest Diagnostics Incorporated with multi timeframe chartsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
State of Alaska Department of Revenue Has $2.25 Million Stock Position in Quest Diagnostics Incorporated $DGX - Defense World
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quest Diagnostics Inc Stock (DGX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
PREVOZNIK MICHAEL E | SVP & General Counsel |
Sep 26 '25 |
Sale |
188.13 |
227 |
42,706 |
38,117 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):